Day: November 23, 2021

LONDON, Nov. 23, 2021 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for patients suffering from inherited systemic debilitating diseases, today announced that the Company will participate in the Evercore ISI 4th Annual HealthCONx Conference. Freeline Chief Executive Officer Michael Parini is scheduled to participate in a Fireside Chat at the event on December 2, 2021 at 3:55 p.m. EST. A webcast of the Fireside Chat will be available on the Investors section of the Freeline website for approximately 90 days. Senior management will participate in virtual one-on-one meetings with investors throughout the conference. About Freeline Therapeutics Freeline is a clinical-stage biotechnology...

TORONTO, Nov. 23, 2021 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres” or the “Trust”) (TSX:SRU.UN) announced today that the trustees of SmartCentres have declared a distribution for the month of November 2021 of CDN $0.15417 per trust unit, representing CDN $1.85 per unit on an annualized basis. Payment will be made on December 15, 2021 to unitholders of record on November 30, 2021. About SmartCentres SmartCentres Real Estate Investment Trust is one of Canada’s largest fully integrated REITs, with a best-in-class portfolio featuring 168 strategically located properties in communities across the country. SmartCentres has approximately $10.2 billion in assets and owns 34.0 million square feet of income producing value-oriented retail space with 97.6% occupancy, on 3,500 acres of owned land across Canada. SmartCentres...

HINGHAM, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ:HIFS) (“the Bank”), Hingham, Massachusetts, announced that its Board of Directors has declared a regular quarterly cash dividend of $0.55 per share. This represents an increase of 4% over the previous regular quarterly dividend of $0.53 per share. The dividend will be paid on January 12, 2022 to stockholders of record as of January 3, 2022. In addition to the regular quarterly dividend, the Bank’s Board of Directors announced that it will pay a special dividend of $0.75 per share. This special dividend will also be paid on January 12, 2022 to stockholders of record as of January 3, 2022. In November 2020, the Bank declared a special dividend of $0.70 per share. Robert H. Gaughen, Jr., Chairman and Chief Executive Officer of the Bank,...

Third Quarter 2021 Revenues of $8.0 Million Marks another Record and Fourth Consecutive Quarter of Positive Adjusted EBITDA(1) PORTLAND, Ore., Nov. 23, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (“Chalice” or the “Company”), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, today announces its financial and operating results for the third quarter 2021. All amounts stated are in US Dollars unless otherwise noted. Third Quarter Highlights:Record quarterly revenues from continuing operations of $8.0 million, a 29% year-over-year increase compared to $6.2 million for the same period in 2020, in part driven by a full quarter of revenues from the Company’s Homegrown Oregon stores. 63.7% growth in gross profit for third quarter 2021 of...

FLORHAM PARK, N.J., Nov. 23, 2021 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate virtually in the 4th Annual Evercore ISI HealthCONx Conference on Tuesday, November 30, 2021 at 9:15 a.m. EST. Members of Phathom’s management team will also participate in one-on-one meetings throughout the conference which runs from November 30 – December 2, 2021. To access the live webcast and archived recording of the presentation, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. The recording will be available for 90 days following the...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES PORTLAND, Ore., Nov. 23, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (“Chalice” or the “Company”), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, today announced that it has closed its previously announced brokered private placement of unsecured convertible debenture units and equity units (the “Offering“) led by Canaccord Genuity Corp. (“Canaccord Genuity” or the “Agent“) as sole agent and bookrunner. Pursuant to the Offering, the Company issued, for gross proceeds of C$5.7 million: (a) 4,025 debenture units (the “Debenture...

SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced that it has received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“NASDAQ”) notifying the company that based on the company’s filing of its Quarterly Reports on Form 10-Q for the periods ended March 31, 2021, June 30, 2021 and September 30, 2021, the company has regained compliance with NASDAQ Marketplace Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission, and that the matter is now closed. About Adamis Pharmaceuticals Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical...

LEESBURG, Va., Nov. 23, 2021 (GLOBE NEWSWIRE) — Quantum Computing Inc. (QCI) (Nasdaq: QUBT), a quantum software leader in bridging the power of classical and quantum computing, has been invited to present at the Benchmark Discovery 1×1 Investor Conference being held virtually on December 2, 2021. QCI CEO Robert Liscouski and CFO Chris Roberts will participate in one-on-one meetings with institutional analysts and investors. They will discuss the company’s Qatalyst™ ready-to-run quantum software which was recently selected for the final round of the BMW Group and Amazon Web Services (AWS) Quantum Computing Challenge in the vehicle sensor placement category. Earlier this year, QCI entered a technology collaboration with AWS which enabled Qatalyst users to access quantum computers via AWS Braket, including those offered by D-Wave,...